Page 271 - Read Online
P. 271

Vasefi et al. Vessel Plus 2020;4:24  I  http://dx.doi.org/10.20517/2574-1209.2020.16                                                  Page 7 of 11
                                                                                              [95]
                          [94]
               with HAND . Stroke patients have higher levels of circulating PDGFb receptor-positive cells . PDGF-BB
               is consistently among the growing number of proteins and molecules identified as biomarkers in the CSF
                                                                       [99]
               of AD patients [96-98]  and is potentially a serum biomarker for PD . PDGF-BB levels are also elevated in
                                                                                                 [101]
                                                   [100]
               patients with amyotrophic lateral sclerosis . PDGF-BB may be a biomarker for schizophrenia  as well
                                                                                                  [102]
               as having links to the disease via genetic differences in both PDGF-B and PDGFb receptor genes . Last,
               mutations in PDGF-B and PDGFb receptor genes are both biomarkers for, and causative agents of, familial
               brain calcification [103,104] .
               CONCLUSION
               PDGF signaling is crucial for healthy CNS development. In recent years, its role in the developed CNS,
               and even in the aging CNS, has been linked to various neuropathologies and neuroprotective pathways.
               Understanding, and possibly targeting, the PDGF system will be crucial to our understanding and
               treatment of stroke and neuronal damage, dementias including HAND and Alzheimer’s disease, and in
               Parkinson’s disease. In addition to understanding ligand-activated PDGF receptor signaling, indirect,
               GPCR-mediated transactivation of the PDGFb receptor, provides a link between GPCR-targeted therapies
               and PDGF system changes.


               DECLARATIONS
               Authors’ contributions
               Made substantial contributions to conception and design of the study: Vasefi M, Beazely MA
               Participated in drafting the article and revising the content: Vasefi M
               Contributed in revising the article and approved the revised version: Beazely MA

               Availability of data and materials
               Not applicable


               Financial support and sponsorship
               None.


               Conflicts of interest
               Both authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2020.

               REFERENCES
               1.   Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta
                   1998;1378:F79-113.
               2.   Kazlauskas A. PDGFs and their receptors. Gene 2017;614:1-7.
               3.   Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79:1283-316.
               4.   Sil S, Periyasamy P, Thangaraj A, Chivero ET, Buch S. PDGF/PDGFR axis in the neural systems. Mol Aspects Med 2018;62:63-74.
               5.   Williams BP, Park JK, Alberta JA, Muhlebach SG, Hwang GY, et al. A PDGF-regulated immediate early gene response initiates neuronal
                   differentiation in ventricular zone progenitor cells. Neuron 1997;18:553-62.
               6.   Smits A, Kato M, Westermark B, Nister M, Heldin CH, et al. Neurotrophic activity of platelet-derived growth factor (PDGF): rat neuronal
   266   267   268   269   270   271   272   273   274   275   276